Approvals/TGA/APOHEALTH ACUTE MIGRAINE RELIEF SUMATRIPTAN TABLETS sumatriptan 50 mg (as succinate) tablet blister pack

Approved

STANDARD

APOHEALTH ACUTE MIGRAINE RELIEF SUMATRIPTAN TABLETS sumatriptan 50 mg (as succinate) tablet blister pack

Arrotex Pharmaceuticals Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: a4e0f70d917c297c
Product Name: APOHEALTH ACUTE MIGRAINE RELIEF SUMATRIPTAN TABLETS sumatriptan 50 mg (as succinate) tablet blister pack
Artg Id: 401753
Artg Name: APOHEALTH ACUTE MIGRAINE RELIEF SUMATRIPTAN TABLETS sumatriptan 50 mg (as succinate) tablet blister pack
Sponsor: Arrotex Pharmaceuticals Pty Ltd
Company Detail Path: /organization/arrotex-pharmaceuticals-pty-ltd
Artg Date: 2023-01-03
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

a4e0f70d917c297c

Type

Standard